Literature DB >> 22143770

Structural insights into protein arginine symmetric dimethylation by PRMT5.

Litao Sun1, Mingzhu Wang, Zongyang Lv, Na Yang, Yingfang Liu, Shilai Bao, Weimin Gong, Rui-Ming Xu.   

Abstract

Symmetric and asymmetric dimethylation of arginine are isomeric protein posttranslational modifications with distinct biological effects, evidenced by the methylation of arginine 3 of histone H4 (H4R3): symmetric dimethylation of H4R3 leads to repression of gene expression, while asymmetric dimethylation of H4R3 is associated with gene activation. The enzymes catalyzing these modifications share identifiable sequence similarities, but the relationship between their catalytic mechanisms is unknown. Here we analyzed the structure of a prototypic symmetric arginine dimethylase, PRMT5, and discovered that a conserved phenylalanine in the active site is critical for specifying symmetric addition of methyl groups. Changing it to a methionine significantly elevates the overall methylase activity, but also converts PRMT5 to an enzyme that catalyzes both symmetric and asymmetric dimethylation of arginine. Our results demonstrate a common catalytic mechanism intrinsic to both symmetric and asymmetric arginine dimethylases, and show that steric constrains in the active sites play an essential role in determining the product specificity of arginine methylases. This discovery also implies a potentially regulatable outcome of arginine dimethylation that may provide versatile control of eukaryotic gene expression.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22143770      PMCID: PMC3251124          DOI: 10.1073/pnas.1106946108

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  34 in total

1.  Crystal structure of the conserved core of protein arginine methyltransferase PRMT3.

Authors:  X Zhang; L Zhou; X Cheng
Journal:  EMBO J       Date:  2000-07-17       Impact factor: 11.598

2.  Methylation of Sm proteins by a complex containing PRMT5 and the putative U snRNP assembly factor pICln.

Authors:  G Meister; C Eggert; D Bühler; H Brahms; C Kambach; U Fischer
Journal:  Curr Biol       Date:  2001-12-11       Impact factor: 10.834

3.  Methylation of histone H4 at arginine 3 occurs in vivo and is mediated by the nuclear receptor coactivator PRMT1.

Authors:  B D Strahl; S D Briggs; C J Brame; J A Caldwell; S S Koh; H Ma; R G Cook; J Shabanowitz; D F Hunt; M R Stallcup; C D Allis
Journal:  Curr Biol       Date:  2001-06-26       Impact factor: 10.834

4.  Prmt5, which forms distinct homo-oligomers, is a member of the protein-arginine methyltransferase family.

Authors:  J Rho; S Choi; Y R Seong; W K Cho; S H Kim; D S Im
Journal:  J Biol Chem       Date:  2001-01-10       Impact factor: 5.157

5.  The methylosome, a 20S complex containing JBP1 and pICln, produces dimethylarginine-modified Sm proteins.

Authors:  W J Friesen; S Paushkin; A Wyce; S Massenet; G S Pesiridis; G Van Duyne; J Rappsilber; M Mann; G Dreyfuss
Journal:  Mol Cell Biol       Date:  2001-12       Impact factor: 4.272

6.  The structure and oligomerization of the yeast arginine methyltransferase, Hmt1.

Authors:  V H Weiss; A E McBride; M A Soriano; D J Filman; P A Silver; J M Hogle
Journal:  Nat Struct Biol       Date:  2000-12

7.  PRMT5 (Janus kinase-binding protein 1) catalyzes the formation of symmetric dimethylarginine residues in proteins.

Authors:  T L Branscombe; A Frankel; J H Lee; J R Cook; Z Yang ; S Pestka; S Clarke
Journal:  J Biol Chem       Date:  2001-06-18       Impact factor: 5.157

8.  The human homologue of the yeast proteins Skb1 and Hsl7p interacts with Jak kinases and contains protein methyltransferase activity.

Authors:  B P Pollack; S V Kotenko; W He; L S Izotova; B L Barnoski; S Pestka
Journal:  J Biol Chem       Date:  1999-10-29       Impact factor: 5.157

9.  Methylation of histone H4 at arginine 3 facilitating transcriptional activation by nuclear hormone receptor.

Authors:  H Wang; Z Q Huang; L Xia; Q Feng; H Erdjument-Bromage; B D Strahl; S D Briggs; C D Allis; J Wong; P Tempst; Y Zhang
Journal:  Science       Date:  2001-05-31       Impact factor: 47.728

10.  Size-distribution analysis of macromolecules by sedimentation velocity ultracentrifugation and lamm equation modeling.

Authors:  P Schuck
Journal:  Biophys J       Date:  2000-03       Impact factor: 4.033

View more
  48 in total

Review 1.  The PRMT5 arginine methyltransferase: many roles in development, cancer and beyond.

Authors:  Nicole Stopa; Jocelyn E Krebs; David Shechter
Journal:  Cell Mol Life Sci       Date:  2015-02-07       Impact factor: 9.261

Review 2.  PRMT7 as a unique member of the protein arginine methyltransferase family: A review.

Authors:  Kanishk Jain; Steven G Clarke
Journal:  Arch Biochem Biophys       Date:  2019-02-22       Impact factor: 4.013

Review 3.  The promise and failures of epigenetic therapies for cancer treatment.

Authors:  Pasano Bojang; Kenneth S Ramos
Journal:  Cancer Treat Rev       Date:  2013-07-05       Impact factor: 12.111

Review 4.  Chemical biology of protein arginine modifications in epigenetic regulation.

Authors:  Jakob Fuhrmann; Kathleen W Clancy; Paul R Thompson
Journal:  Chem Rev       Date:  2015-05-13       Impact factor: 60.622

5.  Cloning, expression, purification and preliminary X-ray crystallographic analysis of mouse protein arginine methyltransferase 7.

Authors:  Vincent Cura; Nathalie Troffer-Charlier; Marie-Annick Lambert; Luc Bonnefond; Jean Cavarelli
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2013-12-24       Impact factor: 1.056

6.  Structural basis of arginine asymmetrical dimethylation by PRMT6.

Authors:  Hong Wu; Weihong Zheng; Mohammad S Eram; Mynol Vhuiyan; Aiping Dong; Hong Zeng; Hao He; Peter Brown; Adam Frankel; Masoud Vedadi; Minkui Luo; Jinrong Min
Journal:  Biochem J       Date:  2016-08-01       Impact factor: 3.857

Review 7.  Readers of histone methylarginine marks.

Authors:  Sitaram Gayatri; Mark T Bedford
Journal:  Biochim Biophys Acta       Date:  2014-02-28

8.  A selective inhibitor of PRMT5 with in vivo and in vitro potency in MCL models.

Authors:  Elayne Chan-Penebre; Kristy G Kuplast; Christina R Majer; P Ann Boriack-Sjodin; Tim J Wigle; L Danielle Johnston; Nathalie Rioux; Michael J Munchhof; Lei Jin; Suzanne L Jacques; Kip A West; Trupti Lingaraj; Kimberly Stickland; Scott A Ribich; Alejandra Raimondi; Margaret Porter Scott; Nigel J Waters; Roy M Pollock; Jesse J Smith; Olena Barbash; Melissa Pappalardi; Thau F Ho; Kelvin Nurse; Khyati P Oza; Kathleen T Gallagher; Ryan Kruger; Mikel P Moyer; Robert A Copeland; Richard Chesworth; Kenneth W Duncan
Journal:  Nat Chem Biol       Date:  2015-04-27       Impact factor: 15.040

9.  Glutathionylation Decreases Methyltransferase Activity of PRMT5 and Inhibits Cell Proliferation.

Authors:  Meiqi Yi; Yingying Ma; Yuling Chen; Chongdong Liu; Qingtao Wang; Haiteng Deng
Journal:  Mol Cell Proteomics       Date:  2020-08-31       Impact factor: 5.911

10.  Crystal structure of the human PRMT5:MEP50 complex.

Authors:  Stephen Antonysamy; Zahid Bonday; Robert M Campbell; Brandon Doyle; Zhanna Druzina; Tarun Gheyi; Bomie Han; Louis N Jungheim; Yuewei Qian; Charles Rauch; Marijane Russell; J Michael Sauder; Stephen R Wasserman; Kenneth Weichert; Francis S Willard; Aiping Zhang; Spencer Emtage
Journal:  Proc Natl Acad Sci U S A       Date:  2012-10-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.